Happy New Year! New assays have arrived...

We are very excited to announce the launch of new products from the combined PerkinElmer-Cisbio reagent portfolio.

Using the HTRF^® technology:

4 assays for quantifying endogenous total & phospho-Tau phosphorylated on various serine or threonine sites. These 4 assays, added to the 2 existing ones, complete our HTRF offer in Tau detection.
Tau exists in different states in both Alzheimer’s (AD) and Parkinson’s (PD) Diseases.
Tau hyperphosphorylation is also a marker for multiple neurodegenerative diseases and CNS disorders.
• Phospho-Tau (Ser356) cellular kit
• Phospho-Tau (Ser422) cellular kit
• Phospho-Tau (Thr181) cellular kit
• Total Tau cellular Kit for monitoring the expression level of cellular Tau which can be used as a normalization assay for the phospho-Tau (Ser202/205; Ser356; Ser404; Ser422; Thr181) kits.

1 new test added to the 2 existing HTRF assays for detecting phospho-phospholamban
• Phospho-phospholamban (Ser16) cellular kit

2 assays for the detection of cytokines: human IL-11 and mouse IFN-beta, increasing the available cytokine offering to 40 products,

2 binding kits to identify inhibitors of protein/protein interactions
• Human TNFalpha/TNFReceptor1 binding kit
• Human CD47/SIRP alpha biochemical binding kit

Using the AlphaLISA^® Surefire^® Ultra^TM technology:

• Phospho-Rb (Ser807/811)
• Phospho-Rb (Thr821/826)
• Total Rb
• Total STAT4
• Total STAT6

Using the Alpha Surefire^® Ultra^TM Multiplex technology:

• phospho-AMPKα1/2 (Thr172) + Total AMPKα1/2
• phospho-Cofilin (Ser3) + Total Cofilin
• phospho-PDGF Receptor β (Tyr751) + Total PDGF Receptor β

Using the AlphaLISA^® technology:

• PD1/PD-L2 (human)

Using the Alpha CETSA^® technology:

• Raf-1

For all the Alpha^® products, please contact your local representatives or visit www.perkinelmer.com.